Jones Kertz & Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.61M Sell
6,344
-1,015
-14% -$237K 0.74% 37
2026
Q1
$1.8M Hold
7,359
0.96% 31
2025
Q4
$1.52M Buy
+7,359
New +$1.46M 0.78% 37

Other funds holding JNJ

Jones Kertz & Associates's JNJ Position: Q2 2026 in Review

Jones Kertz & Associates reduced its Johnson & Johnson (JNJ) stake by 14% in Q2 2026, selling an estimated $237K and leaving 6,344 shares worth $1.61M. The position accounts for 0.74% of the portfolio, ranked #37.

Jones Kertz & Associates first reported a position in JNJ in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.8M in Q1 2026. 2,987 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Jones Kertz & Associates held 6,344 shares of Johnson & Johnson worth $1.61M as of Q2 2026.
  • Jones Kertz & Associates sold 1,015 Johnson & Johnson shares in Q2 2026, an estimated $237K.
  • Johnson & Johnson made up 0.74% of Jones Kertz & Associates's portfolio in Q2 2026, its #37 holding.
  • Jones Kertz & Associates first reported a position in Johnson & Johnson in Q4 2025 and has held it in 3 quarters since.
  • Jones Kertz & Associates's Johnson & Johnson position peaked at $1.8M in Q1 2026.
  • 2,987 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Jones Kertz & Associates's 13F filing for Q2 2026, filed 23 Jul 2026.